{
  "data": {
    "financials": {
      "sales_growth_3yr_avg": 7.4,
      "profit_growth_3yr_avg": 20.4,
      "roe_latest": 17.8,
      "roce_latest": 22.7,
      "pe_ratio": 22.3,
      "debt_to_equity": 0.01,
      "beta": 0.55
    },
    "dcf_inputs": {
      "free_cash_flow_latest_cr": 2784,
      "growth_rate_projection": 10,
      "shares_outstanding_cr": 80.75,
      "net_debt_cr": -7708,
      "tax_rate": 22.5
    },
    "qualitative": {
      "management_integrity_score": 9,
      "reasoning": "Cipla is widely respected for its 'Caring for Life' philosophy and affordable medicines (e.g., HIV/AIDS crusade). The company maintains a net-cash positive balance sheet and high corporate governance standards. A strong internal culture of quality compliance is evident from leadership statements emphasizing integrity over speed, and the company has successfully navigated regulatory audits with relatively few major escalations compared to peers."
    }
  },
  "_cached_at": "2025-12-24T22:02:41.844257",
  "_symbol": "CIPLA"
}